Correspondence: Dr. A. Baloira Villar. Sección de Neumología. Complexo Hospitalario de Pontevedra. Mourente. 36071 Pontevedra. España
was read the article
array:23 [ "pii" => "S1579212906604138" "issn" => "15792129" "doi" => "10.1016/S1579-2129(06)60413-8" "estado" => "S300" "fechaPublicacion" => "2005-03-01" "aid" => "60413" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica (SEPAR)" "copyrightAnyo" => "2005" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2005;41:130-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2890 "formatos" => array:3 [ "EPUB" => 104 "HTML" => 1834 "PDF" => 952 ] ] "itemSiguiente" => array:18 [ "pii" => "S157921290660414X" "issn" => "15792129" "doi" => "10.1016/S1579-2129(06)60414-X" "estado" => "S300" "fechaPublicacion" => "2005-03-01" "aid" => "60414" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica (SEPAR)" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2005;41:135-40" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2351 "formatos" => array:3 [ "EPUB" => 101 "HTML" => 1608 "PDF" => 642 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Articles</span>" "titulo" => "Veracity of Smokers' Response Regarding Abstinence at Smoking Cessation Clinics" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "135" "paginaFinal" => "140" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Barrueco, C. Jiménez Ruiz, L. Palomo, M. Torrecilla, P. Romero, J.A. Riesco" "autores" => array:6 [ 0 => array:3 [ "preGrado" => "Dr." "nombre" => "M." "apellidos" => "Barrueco" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Jiménez Ruiz" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Palomo" ] 3 => array:2 [ "nombre" => "M." "apellidos" => "Torrecilla" ] 4 => array:2 [ "nombre" => "P." "apellidos" => "Romero" ] 5 => array:2 [ "nombre" => "J.A." "apellidos" => "Riesco" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157921290660414X?idApp=UINPBA00003Z" "url" => "/15792129/0000004100000003/v1_201305150210/S157921290660414X/v1_201305150210/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1579212906604126" "issn" => "15792129" "doi" => "10.1016/S1579-2129(06)60412-6" "estado" => "S300" "fechaPublicacion" => "2005-03-01" "aid" => "60412" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica (SEPAR)" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2005;41:125-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2213 "formatos" => array:3 [ "EPUB" => 112 "HTML" => 1464 "PDF" => 637 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Importance of Routine Mediastinal Staging in Women With Nonsmall Cell Lung Cancer" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "125" "paginaFinal" => "129" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.L. Martín de Nicolás, A. Gómez-Caro Andrés, F.J. Moradiellos Díez, V. Díaz-Hellín, O. Gigirey Castro, E. Larrú Cabrero, J.A. Pérez Antón, C. Marrón Fernández" "autores" => array:8 [ 0 => array:2 [ "nombre" => "J.L." "apellidos" => "Martín de Nicolás" ] 1 => array:3 [ "preGrado" => "Dr." "nombre" => "A." "apellidos" => "Gómez-Caro Andrés" ] 2 => array:2 [ "nombre" => "F.J." "apellidos" => "Moradiellos Díez" ] 3 => array:2 [ "nombre" => "V." "apellidos" => "Díaz-Hellín" ] 4 => array:2 [ "nombre" => "O." "apellidos" => "Gigirey Castro" ] 5 => array:2 [ "nombre" => "E." "apellidos" => "Larrú Cabrero" ] 6 => array:2 [ "nombre" => "J.A." "apellidos" => "Pérez Antón" ] 7 => array:2 [ "nombre" => "C. Marrón" "apellidos" => "Fernández" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212906604126?idApp=UINPBA00003Z" "url" => "/15792129/0000004100000003/v1_201305150210/S1579212906604126/v1_201305150210/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Articles</span>" "titulo" => "Bronchodilator Efficacy of Combined Salmeterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "130" "paginaFinal" => "134" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Baloira Villar, C. Vilariño Pombo" "autores" => array:2 [ 0 => array:5 [ "preGrado" => "Dr." "nombre" => "A." "apellidos" => "Baloira Villar" "email" => array:1 [ 0 => "adolfobalo@eresmas.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor1" ] ] ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Vilariño Pombo" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Sección de Neumología, Complexo Hospitalario de Pontevedra, Mourente, Pontevedra, Spain" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "*" "correspondencia" => "Correspondence: Dr. A. Baloira Villar. Sección de Neumología. Complexo Hospitalario de Pontevedra. Mourente. 36071 Pontevedra. España" ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2004-03-24" "fechaAceptado" => "2004-03-31" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key Words" "identificador" => "xpalclavsec153978" "palabras" => array:4 [ 0 => "Chronic obstructive pulmonary disease (COPD)" 1 => "Salmeterol" 2 => "Tiotropium" 3 => "Spirometry" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec153977" "palabras" => array:4 [ 0 => "Enfermedad pulmonar obstructiva crónica (EPOC)" 1 => "Salmeterol" 2 => "Tiotropio" 3 => "Espirometría" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Objective</span><p class="elsevierStyleSimplePara elsevierViewall">Bronchodilators are still the most effective drugs for controlling the symptoms of chronic obstructive pulmonary disease (COPD). Tiotropium bromide, a long-acting anticholinergic drug, has recently been added to the therapeutic arsenal for the disease. To date, there have been no studies combining 2 long-acting bronchodilators. The aim of the present trial was to determine whether the combination of salmeterol and tiotropium improved lung function in COPD patients more than either of them alone.</p> <span class="elsevierStyleSectionTitle">Patients and methods</span><p class="elsevierStyleSimplePara elsevierViewall">Twenty-two patients (20 men) diagnosed with COPD, with a mean age of 64 years, were enrolled in this cross-over trial. Active smokers were excluded. Mean (SD) forced expiratory volume in 1 second (FEV<span class="elsevierStyleInf">1</span>) was 43% (14%) of predicted. All patients were experienced in the use of inhalers. The following 3 therapeutic combinations were randomly assigned to be administered for a 1-week period: <span class="elsevierStyleItalic">a</span>) fluticasone (500 μg/12 h), salmeterol (50 μg/12 h) and placebo; <span class="elsevierStyleItalic">b</span>) fluticasone, tiotropium (18 μg/24 h), and placebo; and <span class="elsevierStyleItalic">c</span>) fluticasone, salmeterol, and tiotropium. At the end of each period, forced spirometry was performed before inhalation of the therapeutic combination (between 8:30 AM and 9:30 AM) and 2 hours after inhalation. Throughout the week, morning peak flow rates measured immediately before inhalation were recorded, and there was a 48-hour wash-out period between each therapeutic combination.</p> <span class="elsevierStyleSectionTitle">Results</span><p class="elsevierStyleSimplePara elsevierViewall">All the patients completed the protocol. There were no significant differences in preinhalation or postinhalation FEV<span class="elsevierStyleInf">1</span> with salmeterol compared to tiotropium (preinhalation FEV<span class="elsevierStyleInf">1</span>, 1.17 [0.55] L compared to 1.19 [0.49] L; postinhalation FEV<span class="elsevierStyleInf">1</span>, 1.32 [0.65] L compared to 1.29 [0.61] L). In all cases postinhalation FEV<span class="elsevierStyleInf">1</span> was significantly higher than preinhalation FEV<span class="elsevierStyleInf">1</span>. The combination of fluticasone, salmeterol, and tiotropium proved superior to the other 2 combinations with respect to both preinhalation FEV1 and postinhalation FEV<span class="elsevierStyleInf">1</span> (preinhalation FEV<span class="elsevierStyleInf">1</span>, 1.32 [0.56] L, [<span class="elsevierStyleItalic">P</span> <.03 in both comparisons]; postinhalation FEV<span class="elsevierStyleInf">1</span>, 1.49 [0.68] L [<span class="elsevierStyleItalic">P</span> <.001 in both comparisons]). Peak flow rate was also significantly higher with the combination of the 2 bronchodilators (345 L/min compared to 291 L/min and 311 mL, respectively [<span class="elsevierStyleItalic">P</span> <.04 in both cases]). There were no notable side effects.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p class="elsevierStyleSimplePara elsevierViewall">In terms of improvement in lung function, the combination of salmeterol and tiotropium together with fluticasone is more effective in patients with moderate-to-severe COPD than either of the 2 bronchodilators administered alone.</p>" ] "es" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Objetivo</span><p class="elsevierStyleSimplePara elsevierViewall">LOS broncodilatadores continúan siendo los fármacos más eficaces para el control de los síntomas de la enfermedad pulmonar obstructiva crónica (EPOC). Recien-temente se ha añadido un anticolinérgico de acción larga, el bromuro de tiotropio, al arsenal terapéutico de esta enfermedad. No existen estudios que hayan asociado 2 broncodilatadores de acción sostenida. El objetivo de este estudio ha sido comprobar si la asociación de salmeterol y tiotropio a pacientes con EPOC mejora la función pulmonar respecto a cuando se administran aislados.</p> <span class="elsevierStyleSectionTitle">Pacientes Y Métodos</span><p class="elsevierStyleSimplePara elsevierViewall">Se incluyó en el estudio a 22 pacientes diagnosticados de EPOC (20 varones), con una edad media de 64 años. Se excluyó a los fumadores activos. El volumen espira-torio forzado en el primer segundo (FEV<span class="elsevierStyleInf">1</span>) medio (± desviación estándar) fue un 43 ± 14% del teórico. Todos los pacientes tenían amplia experiencia en el uso de los dispositivos de inhalación. Se realizaron 3 combinaciones terapéuticas de forma aleatoria durante una semana: <span class="elsevierStyleItalic">a</span>) fluticasona (500 μg/12 h), salmeterol (50 μg/12 h) y placebo; <span class="elsevierStyleItalic">b</span>) fluticasona, tiotropio (18 μg/24 h) y placebo, y <span class="elsevierStyleItalic">c</span>) fluticasona, salmeterol y tiotropio. Al final de cada período se realizó una espirometría forzada entre las 8.30 y las 9.00 h, antes de la inhalación de la combinación y 2 h después de ésta. Durante toda la semana se recogió el pico de flujo ma-tutino inmediatamente antes de la inhalación de los fármacos, dejando 48 h de lavado entre cada asociación.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p class="elsevierStyleSimplePara elsevierViewall">Todos los pacientes finalizaron el protocolo. No hubo diferencias significativas en el FEV<span class="elsevierStyleInf">1</span> tanto valle como postinhalación con salmeterol y tiotropio (FEV<span class="elsevierStyleInf">1</span> valle: 1,17 ± 0,55 frente a 1,19 ± 0,49 l; FEV<span class="elsevierStyleInf">1</span> postinhalación: 1,32 ± 0,65 frente a 1,29 ± 0,61 l). En todos los casos el FEV<span class="elsevierStyleInf">1</span> postinhalación fue significativamente superior al FEV<span class="elsevierStyleInf">1</span> valle. La combinación de fluticasona, salmeterol y tiotropio se mostró superior a las otras 2 tanto en el FEV<span class="elsevierStyleInf">1</span> valle como postinhalación (FEV1 valle: 1,32 ± 0,56 l, p < 0,03 en ambos casos; FEV<span class="elsevierStyleInf">1</span> postinhalación: 1,49 ± 0,68 l, p < 0,001 en los 2 casos). El pico de flujo también fue significativamente mayor con la combinación de los 2 broncodilatadores (345 frente a 291 l/m y 311 l/m, respectivamente; p < 0,04 en ambos casos). No hubo efectos secundarios reseñables.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p class="elsevierStyleSimplePara elsevierViewall">La asociación de salmeterol y tiotropio unidos a fluticasona en pacientes con EPOC de grado mode-rado-grave es más eficaz en términos de mejoría funcional respiratoria que cualquiera de los 2 broncodilatadores dados de forma aislada.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "REFERENCES" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:21 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V Sobradillo" 1 => "M Miravitlles" 2 => "CA Jiménez" 3 => "R Gabriel" 4 => "JL Viejo" 5 => "JF Masa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol." "fecha" => "1999" "volumen" => "35" "paginaInicial" => "159" "paginaFinal" => "166" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10330536" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alternative projection of mortality by cause 1999-2020: Global Burden of Disease study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "CJ Murray" 1 => "AD López" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(96)07492-2" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1997" "volumen" => "349" "paginaInicial" => "1498" "paginaFinal" => "1504" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9167458" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of long-acting bronchodilators in the management of stable COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "DP Tashkin" 1 => "CB Cooper" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2004" "volumen" => "125" "paginaInicial" => "249" "paginaFinal" => "259" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14718448" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "DS Postma" 1 => "HA Kerstjens" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Respir Crit Care Med." "fecha" => "1999" "volumen" => "166" "paginaInicial" => "S66" "paginaFinal" => "S71" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "PM Calverley" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Res Crit Care Med." "fecha" => "2000" "volumen" => "161" "paginaInicial" => "341" "paginaFinal" => "342" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "PS Barnes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Res Crit Care Med." "fecha" => "2000" "volumen" => "161" "paginaInicial" => "342" "paginaFinal" => "344" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E Gamble" 1 => "DC Govtendorst" 2 => "CE Brightling" 3 => "S Troy" 4 => "Y Qiu" 5 => "J Zhu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200212-1490OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med." "fecha" => "2003" "volumen" => "168" "paginaInicial" => "976" "paginaFinal" => "982" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12816740" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G Boyd" 1 => "AH Morice" 2 => "JC Pounsford" 3 => "M Siebert" 4 => "M Peslis" 5 => "C Crawford" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J." "fecha" => "1997" "volumen" => "10" "paginaInicial" => "815" "paginaFinal" => "821" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9150318" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quality of life changes in COPD patients treated with salmeterol" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "PW Jones" 1 => "TK Bosch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.155.4.9105068" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med." "fecha" => "1997" "volumen" => "155" "paginaInicial" => "1283" "paginaFinal" => "1289" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9105068" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R Dahl" 1 => "L Greefhorst" 2 => "D Nowark" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.164.5.2007006" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med." "fecha" => "2001" "volumen" => "164" "paginaInicial" => "778" "paginaFinal" => "784" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11549532" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R Casaburi" 1 => "DA Mahler" 2 => "PW Jones" 3 => "A Wanner" 4 => "G San Pedro" 5 => "RL Zuwallack" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J." "fecha" => "2002" "volumen" => "19" "paginaInicial" => "217" "paginaFinal" => "224" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11866001" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W Vincken" 1 => "JA van Noord" 2 => "APM Greefhorst" 3 => "ThA Bantje" 4 => "S Kesten" 5 => "L Korducki" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J." "fecha" => "2002" "volumen" => "19" "paginaInicial" => "209" "paginaFinal" => "216" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11871363" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A 6-month placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "JF Donohue" 1 => "JA van Noord" 2 => "ED Bateman" 3 => "SJ Langley" 4 => "A Lee" 5 => "TJ Witek Jr" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2002" "volumen" => "122" "paginaInicial" => "47" "paginaFinal" => "55" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12114338" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P Calverley" 1 => "R Pawels" 2 => "J Vestbo" 3 => "P Jones" 4 => "N Pride" 5 => "A Gulsvik" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(03)12459-2" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2003" "volumen" => "361" "paginaInicial" => "449" "paginaFinal" => "456" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12583942" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W Szafranski" 1 => "A Cukier" 2 => "A Ramírez" 3 => "G Menga" 4 => "R Sansores" 5 => "S Nahabedian" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J." "fecha" => "2003" "volumen" => "21" "paginaInicial" => "74" "paginaFinal" => "81" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12570112" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Normativa para la práctica de la espirometría forzada" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Grupo de trabajo de la SEPAR" "etal" => false "autores" => array:1 [ 0 => "J Sanchís" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arch Bronconeumol." "fecha" => "1989" "volumen" => "25" "paginaInicial" => "132" "paginaFinal" => "142" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quality of life changes in COPD patients treated with salmeterol" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "WP Jones" 1 => "TK Bosch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.155.4.9105068" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med." "fecha" => "1997" "volumen" => "155" "paginaInicial" => "1283" "paginaFinal" => "1289" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9105068" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bronchodilator response in chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "NR Anthonisen" 1 => "EC Wright" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am Rev Respir Dis." "fecha" => "1986" "volumen" => "133" "paginaInicial" => "814" "paginaFinal" => "819" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3706890" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A self-complete measure of health status for chronic airflow limitation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "PW Jones" 1 => "FH Quirck" 2 => "CM Baveystock" 3 => "P Littlejohns" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm/145.6.1321" "Revista" => array:6 [ "tituloSerie" => "Am Rev Respir Dis." "fecha" => "1992" "volumen" => "145" "paginaInicial" => "1321" "paginaFinal" => "1327" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1595997" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "BJ Lipworth" 1 => "A Imram" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2000" "volumen" => "117" "paginaInicial" => "156" "paginaFinal" => "162" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10631214" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "BL Maesen" 1 => "CJ Westermann" 2 => "VA Duurkens" 3 => "JM van den Bosch" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J." "fecha" => "1999" "volumen" => "13" "paginaInicial" => "1103" "paginaFinal" => "1108" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10414411" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000004100000003/v1_201305150210/S1579212906604138/v1_201305150210/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/15792129/0000004100000003/v1_201305150210/S1579212906604138/v1_201305150210/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212906604138?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 3 | 4 | 7 |
2024 October | 32 | 19 | 51 |
2024 September | 24 | 12 | 36 |
2024 August | 59 | 31 | 90 |
2024 July | 23 | 18 | 41 |
2024 June | 33 | 21 | 54 |
2024 May | 40 | 25 | 65 |
2024 April | 21 | 18 | 39 |
2024 March | 21 | 14 | 35 |
2024 February | 17 | 20 | 37 |
2023 March | 5 | 2 | 7 |
2023 February | 16 | 18 | 34 |
2023 January | 17 | 28 | 45 |
2022 December | 20 | 23 | 43 |
2022 November | 20 | 28 | 48 |
2022 October | 18 | 37 | 55 |
2022 September | 14 | 28 | 42 |
2022 August | 19 | 29 | 48 |
2022 July | 22 | 39 | 61 |
2022 June | 16 | 39 | 55 |
2022 May | 19 | 37 | 56 |
2022 April | 14 | 21 | 35 |
2022 March | 17 | 33 | 50 |
2022 February | 17 | 29 | 46 |
2022 January | 18 | 35 | 53 |
2021 December | 20 | 36 | 56 |
2021 November | 35 | 46 | 81 |
2021 October | 49 | 37 | 86 |
2021 September | 24 | 40 | 64 |
2021 August | 30 | 29 | 59 |
2021 July | 22 | 27 | 49 |
2021 June | 26 | 33 | 59 |
2021 May | 19 | 23 | 42 |
2021 April | 85 | 48 | 133 |
2021 March | 16 | 23 | 39 |
2021 February | 12 | 19 | 31 |
2021 January | 11 | 13 | 24 |
2020 December | 7 | 8 | 15 |
2020 November | 5 | 19 | 24 |
2020 October | 9 | 12 | 21 |
2020 September | 8 | 11 | 19 |
2020 August | 13 | 11 | 24 |
2020 July | 10 | 15 | 25 |
2020 June | 6 | 4 | 10 |
2020 May | 17 | 15 | 32 |
2020 April | 18 | 14 | 32 |
2020 March | 14 | 16 | 30 |
2020 February | 21 | 20 | 41 |
2020 January | 17 | 13 | 30 |
2019 December | 20 | 13 | 33 |
2019 November | 5 | 11 | 16 |
2019 October | 9 | 7 | 16 |
2019 September | 11 | 15 | 26 |
2019 August | 12 | 5 | 17 |
2019 July | 12 | 21 | 33 |
2019 June | 9 | 24 | 33 |
2019 May | 14 | 13 | 27 |
2019 April | 20 | 24 | 44 |
2019 March | 14 | 31 | 45 |
2019 February | 4 | 15 | 19 |
2019 January | 5 | 17 | 22 |
2018 December | 15 | 23 | 38 |
2018 November | 13 | 13 | 26 |
2018 October | 15 | 17 | 32 |
2018 September | 11 | 17 | 28 |
2018 May | 2 | 0 | 2 |
2018 April | 6 | 11 | 17 |
2018 March | 3 | 10 | 13 |
2018 February | 4 | 8 | 12 |
2018 January | 5 | 10 | 15 |
2017 December | 5 | 12 | 17 |
2017 November | 3 | 13 | 16 |
2017 October | 5 | 14 | 19 |
2017 September | 0 | 8 | 8 |
2017 August | 9 | 23 | 32 |
2017 July | 2 | 1 | 3 |
2017 June | 8 | 43 | 51 |
2017 May | 7 | 19 | 26 |
2017 April | 4 | 8 | 12 |
2017 March | 2 | 11 | 13 |
2017 February | 3 | 2 | 5 |
2017 January | 1 | 5 | 6 |
2016 December | 12 | 9 | 21 |
2016 November | 15 | 8 | 23 |
2016 October | 19 | 14 | 33 |
2016 September | 9 | 12 | 21 |
2016 August | 8 | 5 | 13 |
2016 July | 7 | 13 | 20 |
2016 March | 1 | 0 | 1 |
2016 February | 1 | 0 | 1 |
2015 December | 3 | 0 | 3 |
2015 October | 52 | 1 | 53 |
2015 September | 41 | 17 | 58 |
2015 August | 56 | 20 | 76 |
2015 July | 49 | 9 | 58 |
2015 June | 36 | 12 | 48 |
2015 May | 55 | 21 | 76 |
2015 April | 41 | 21 | 62 |
2015 March | 34 | 19 | 53 |
2015 February | 34 | 18 | 52 |
2015 January | 43 | 19 | 62 |
2014 December | 32 | 10 | 42 |
2014 November | 42 | 8 | 50 |
2014 October | 46 | 13 | 59 |
2014 September | 51 | 12 | 63 |
2014 August | 43 | 11 | 54 |
2014 July | 60 | 9 | 69 |
2014 June | 83 | 14 | 97 |
2014 May | 63 | 11 | 74 |
2014 April | 76 | 14 | 90 |
2014 March | 92 | 16 | 108 |
2014 February | 69 | 12 | 81 |
2014 January | 56 | 12 | 68 |
2013 December | 47 | 11 | 58 |
2013 November | 41 | 14 | 55 |
2013 October | 42 | 18 | 60 |
2013 September | 38 | 11 | 49 |
2013 August | 31 | 9 | 40 |
2013 July | 41 | 14 | 55 |
2013 June | 22 | 9 | 31 |
2013 May | 26 | 10 | 36 |
2013 April | 25 | 7 | 32 |
2013 March | 6 | 2 | 8 |